IL25 and graft versus host disease: When analyzing the overall GVHD scores, dKO ILC2s from mice without IL-25 pre-treatment improved the scores compared to the BM + T group (mean scores of 2.53 vs. 3.41, p < 0.0001) (Fig. 4B).